Some recent approaches of biologically active substituted pyridazine and phthalazine drugs
M Asif - Current medicinal chemistry, 2012 - ingentaconnect.com
Nitrogen atom containing heterocyclic compounds, pyridazines, pyridazinones and
phthalazines are important structural feature of many biologically active compounds and …
phthalazines are important structural feature of many biologically active compounds and …
Pharmacophore modeling and three dimensional database searching for drug design using catalyst: recent advances
O Guner, O Clement, Y Kurogi - Current medicinal chemistry, 2004 - ingentaconnect.com
Perceiving a pharmacophore is the first essential step towards understanding the interaction
between a receptor and a ligand. Once a pharmacophore is established, a beneficial use of …
between a receptor and a ligand. Once a pharmacophore is established, a beneficial use of …
History and evolution of the pharmacophore concept in computer-aided drug design
OF Guner - Current topics in medicinal chemistry, 2002 - ingentaconnect.com
With computer-aided drug design established as an integral part of the lead discovery and
optimization process, pharmacophores have become a focal point for conceptualizing and …
optimization process, pharmacophores have become a focal point for conceptualizing and …
Pharmacophore Map** of a Series of 2,4-Diamino-5-deazapteridine Inhibitors of Mycobacterium avium Complex Dihydrofolate Reductase
AK Debnath - Journal of medicinal chemistry, 2002 - ACS Publications
Pharmacophore hypotheses were developed for a series of 2, 4-diamino-5-deazapteridine
inhibitors of Mycobacterium avium complex (MAC) and human dihydrofolate reductase …
inhibitors of Mycobacterium avium complex (MAC) and human dihydrofolate reductase …
Synthesis, spectroscopic, X-ray diffraction, antimicrobial and antitumor studies of Ni (II) and Co (II) complexes derived from 4-acetyl-5, 6-diphenyl-3 (2H)-pyridazinone …
Reactions of the Schiff base ligand derived from 4-acetyl-5, 6-diphenyl-3 (2H)-pyridazinone
and ethylenediamine with Ni (II) and Co (II) using different metal salts; NO 3−, AcO−, ClO 4 …
and ethylenediamine with Ni (II) and Co (II) using different metal salts; NO 3−, AcO−, ClO 4 …
The therapeutic journey of pyridazinone
Pyridazinones have drawn a substantial attention within the field of research analysis and
development. The moiety is a subject matter of intensive research because of its wide …
development. The moiety is a subject matter of intensive research because of its wide …
Comparison of mlr, pls and ga-mlr in qsar analysis
AK Saxena, P Prathipati - SAR and QSAR in Environmental …, 2003 - Taylor & Francis
The use of the internet has evolved in quantitative structure–activity relationship (QSAR)
over the past decade with the development of web based activities like the availability of …
over the past decade with the development of web based activities like the availability of …
Recent advances in selective α1-adrenoreceptor antagonists as antihypertensive agents
Hypertension is one of the most serious health problems of the modern world with a
continuous rise in the number of patients. Selective α1-adrenoreceptor antagonists though …
continuous rise in the number of patients. Selective α1-adrenoreceptor antagonists though …
Binary and ternary copper (II) complexes of a new Schiff base ligand derived from 4-acetyl-5, 6-diphenyl-3 (2H)-pyridazinone: Synthesis, spectral, thermal …
A new Schiff base ligand was synthesized by the reaction of 4-acetyl-5, 6-diphenyl-3 (2H)-
pyridazinone with ethylenediamine. A series of binary copper (II) Schiff base complexes …
pyridazinone with ethylenediamine. A series of binary copper (II) Schiff base complexes …
Pyridazinone: an important element of pharmacophore possessing broad spectrum of activity
S Dubey, PA Bhosle - Medicinal Chemistry Research, 2015 - Springer
In the last few years, the pyridazine derivatives have been found to exhibit a wide range of
pharmacological activities. A large number of research articles and patents described them …
pharmacological activities. A large number of research articles and patents described them …